Cargando…

Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study

BACKGROUND: Nonalcoholic fatty liver disease is characterized by excessive hepatic fat accumulation. Some individuals frequently present elevated gamma-glutamyl transferase (GGT) levels without fatty liver ultrasound images and other abnormal liver enzymes levels. However, whether these individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Hideki, Doi, Haruna, Ko, Tetsuhisa, Fukuma, Taito, Kadono, Toru, Asaeda, Kohei, Kobayashi, Reo, Nakano, Takahiro, Doi, Toshifumi, Nakatsugawa, Yoshikazu, Yamada, Shinya, Nishimura, Takeshi, Tomatsuri, Naoya, Sato, Hideki, Okuyama, Yusuke, Kimura, Hiroyuki, Kishimoto, Etsuko, Nakabe, Nami, Shima, Takatomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350574/
https://www.ncbi.nlm.nih.gov/pubmed/32650722
http://dx.doi.org/10.1186/s12876-020-01369-x
_version_ 1783557294685945856
author Fujii, Hideki
Doi, Haruna
Ko, Tetsuhisa
Fukuma, Taito
Kadono, Toru
Asaeda, Kohei
Kobayashi, Reo
Nakano, Takahiro
Doi, Toshifumi
Nakatsugawa, Yoshikazu
Yamada, Shinya
Nishimura, Takeshi
Tomatsuri, Naoya
Sato, Hideki
Okuyama, Yusuke
Kimura, Hiroyuki
Kishimoto, Etsuko
Nakabe, Nami
Shima, Takatomo
author_facet Fujii, Hideki
Doi, Haruna
Ko, Tetsuhisa
Fukuma, Taito
Kadono, Toru
Asaeda, Kohei
Kobayashi, Reo
Nakano, Takahiro
Doi, Toshifumi
Nakatsugawa, Yoshikazu
Yamada, Shinya
Nishimura, Takeshi
Tomatsuri, Naoya
Sato, Hideki
Okuyama, Yusuke
Kimura, Hiroyuki
Kishimoto, Etsuko
Nakabe, Nami
Shima, Takatomo
author_sort Fujii, Hideki
collection PubMed
description BACKGROUND: Nonalcoholic fatty liver disease is characterized by excessive hepatic fat accumulation. Some individuals frequently present elevated gamma-glutamyl transferase (GGT) levels without fatty liver ultrasound images and other abnormal liver enzymes levels. However, whether these individuals are at an elevated risk for developing fatty liver is unclear. We compared fatty liver change rates and risk factors between individuals with frequently elevated GGT levels and those with normal levels. METHODS: We designed a retrospective cohort study on the basis of complete medical checkup records. One group of individuals had presented normal serum GGT levels during the observation period (Normal-GGT group, n = 2713). Another group had had abnormal elevated serum GGT levels frequently (Abnormal-GGT group, n = 264). We determined the fatty liver change incident rates before and after propensity score matching. We explored confounding factors affecting fatty changes in each group using univariate and multivariate Cox models. RESULTS: The change incidence rates were 5.80/1000 and 10.02/1000 person-years in the Normal-GGT and Abnormal-GGT groups, respectively. After propensity score matching, the incidence rates were 3.08/1000 and 10.18/1000 person-years in the Normal-GGT and Abnormal-GGT groups, respectively (p = 0.026). The factors associated with fatty liver changes in the Normal-GGT group included body mass index (BMI), hemoglobin, alanine aminotransferase (ALT), albumin, triglyceride (TG), fasting blood sugar, and high-density lipoprotein levels. Those in the Abnormal-GGT group were platelet counts and TG. In our multivariable analysis, BMI, ALT, albumin, and TG levels were independent predictors of fatty changes in the Normal-GGT group, and high TG level was the only independent predictor in the Abnormal-GGT group. CONCLUSIONS: The incidence rate of fatty liver change in the Abnormal-GGT group was higher than that in the Normal-GGT group. Consecutive elevated GGT levels increase the risk for fatty liver, and high TG levels in those individuals further independently increase the risk.
format Online
Article
Text
id pubmed-7350574
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73505742020-07-14 Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study Fujii, Hideki Doi, Haruna Ko, Tetsuhisa Fukuma, Taito Kadono, Toru Asaeda, Kohei Kobayashi, Reo Nakano, Takahiro Doi, Toshifumi Nakatsugawa, Yoshikazu Yamada, Shinya Nishimura, Takeshi Tomatsuri, Naoya Sato, Hideki Okuyama, Yusuke Kimura, Hiroyuki Kishimoto, Etsuko Nakabe, Nami Shima, Takatomo BMC Gastroenterol Research Article BACKGROUND: Nonalcoholic fatty liver disease is characterized by excessive hepatic fat accumulation. Some individuals frequently present elevated gamma-glutamyl transferase (GGT) levels without fatty liver ultrasound images and other abnormal liver enzymes levels. However, whether these individuals are at an elevated risk for developing fatty liver is unclear. We compared fatty liver change rates and risk factors between individuals with frequently elevated GGT levels and those with normal levels. METHODS: We designed a retrospective cohort study on the basis of complete medical checkup records. One group of individuals had presented normal serum GGT levels during the observation period (Normal-GGT group, n = 2713). Another group had had abnormal elevated serum GGT levels frequently (Abnormal-GGT group, n = 264). We determined the fatty liver change incident rates before and after propensity score matching. We explored confounding factors affecting fatty changes in each group using univariate and multivariate Cox models. RESULTS: The change incidence rates were 5.80/1000 and 10.02/1000 person-years in the Normal-GGT and Abnormal-GGT groups, respectively. After propensity score matching, the incidence rates were 3.08/1000 and 10.18/1000 person-years in the Normal-GGT and Abnormal-GGT groups, respectively (p = 0.026). The factors associated with fatty liver changes in the Normal-GGT group included body mass index (BMI), hemoglobin, alanine aminotransferase (ALT), albumin, triglyceride (TG), fasting blood sugar, and high-density lipoprotein levels. Those in the Abnormal-GGT group were platelet counts and TG. In our multivariable analysis, BMI, ALT, albumin, and TG levels were independent predictors of fatty changes in the Normal-GGT group, and high TG level was the only independent predictor in the Abnormal-GGT group. CONCLUSIONS: The incidence rate of fatty liver change in the Abnormal-GGT group was higher than that in the Normal-GGT group. Consecutive elevated GGT levels increase the risk for fatty liver, and high TG levels in those individuals further independently increase the risk. BioMed Central 2020-07-10 /pmc/articles/PMC7350574/ /pubmed/32650722 http://dx.doi.org/10.1186/s12876-020-01369-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Fujii, Hideki
Doi, Haruna
Ko, Tetsuhisa
Fukuma, Taito
Kadono, Toru
Asaeda, Kohei
Kobayashi, Reo
Nakano, Takahiro
Doi, Toshifumi
Nakatsugawa, Yoshikazu
Yamada, Shinya
Nishimura, Takeshi
Tomatsuri, Naoya
Sato, Hideki
Okuyama, Yusuke
Kimura, Hiroyuki
Kishimoto, Etsuko
Nakabe, Nami
Shima, Takatomo
Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study
title Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study
title_full Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study
title_fullStr Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study
title_full_unstemmed Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study
title_short Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study
title_sort frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350574/
https://www.ncbi.nlm.nih.gov/pubmed/32650722
http://dx.doi.org/10.1186/s12876-020-01369-x
work_keys_str_mv AT fujiihideki frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT doiharuna frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT kotetsuhisa frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT fukumataito frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT kadonotoru frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT asaedakohei frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT kobayashireo frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT nakanotakahiro frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT doitoshifumi frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT nakatsugawayoshikazu frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT yamadashinya frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT nishimuratakeshi frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT tomatsurinaoya frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT satohideki frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT okuyamayusuke frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT kimurahiroyuki frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT kishimotoetsuko frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT nakabenami frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy
AT shimatakatomo frequentlyabnormalserumgammaglutamyltransferaseactivityisassociatedwithfuturedevelopmentoffattyliveraretrospectivecohortstudy